.png)
-228x228.png)
PRODUCT OVERVIEW & COMPOSITION
Brand / Manufacturer: Bioniche Pharma
Brand / Product Name: CLENA-MED
Active Ingredient: Clenbuterol Hydrochloride USP (40 mcg per tablet)
Pharmacological Class: Selective $\beta_2$-Adrenoreceptor Agonist / Bronchodilator
Bioniche Pharma CLENA-MED contains Clenbuterol Hydrochloride, a potent sympathomimetic agent that selectively targets $\beta_2$-adrenergic receptors. Originally formulated as a long-acting bronchodilator to ease airway resistance, its physiological activation of adrenoreceptors also induces marked thermogenic, metabolic, and central nervous system stimulation.
CLINICAL PHARMACOLOGY & DYNAMICS
By activating $\beta_2$-adrenoreceptors in bronchial smooth muscle, Bioniche Pharma CLENA-MED promotes rapid relaxation of the airways, enhancing pulmonary ventilation and systemic oxygen delivery. Concurrently, its systemic sympathomimetic activity increases basal metabolic rate, elevates aerobic capacity, stimulates the central nervous system, and can induce transient elevations in blood pressure and heart rate.
INDICATIONS & CLINICAL USE
- Prophylaxis and symptomatic treatment of reversible airway obstruction conditions (e.g., bronchial asthma, chronic obstructive pulmonary disease) using Bioniche Pharma formulations.
- Therapeutic relaxation of bronchial smooth muscle to restore respiratory capacity under strict Bioniche Pharma medical guidance.
DOSAGE & ADMINISTRATION
Dosing strategies for Bioniche Pharma CLENA-MED must be carefully individualised, initiated at conservative threshold levels, and closely monitored by a qualified physician to minimize systemic sympathomimetic side effects.
CONTRAINDICATIONS
- Confirmed or suspected acute myocardial infarction, severe ischemic heart disease, or tachyarrhythmias.
- Pregnancy and lactation due to uterine muscle relaxation and potential cardiovascular fetal toxicity.
- Hypersensitivity or severe allergic response to Bioniche Pharma Clenbuterol or any active components in the Bioniche Pharma formulation.
ADVERSE REACTIONS & WARNINGS
Monitoring is required during Bioniche Pharma therapy for potential sympathomimetic and cardiovascular adverse events:
- Cardiovascular: Tachycardia, palpitations, elevated blood pressure, subaortic stenosis aggravation, or increased cardiac stress associated with Bioniche Pharma administration.
- Endocrine & Systemic: Exacerbation of thyrotoxicosis symptoms, fine muscular tremors, anxiety, and restlessness reported by Bioniche Pharma patients.
- Hypersensitivity: Dermatological eruptions, urticaria, or systemic allergic responses experienced during Bioniche Pharma treatment.
STORAGE & HANDLING
Store Bioniche Pharma products in a cool, dry place protected from exposure to direct light and moisture. Keep strictly out of reach and sight of children.